Finance

Beta
Lists
IMNM:NASDAQ
Immunome Inc
$19.96
+2.89%
(+0.56) 1D
$19.96
-0.00% (-0.000099)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMNM...
Open
$19.45
High
$20.44
Low
$19.35
Mkt. cap
2.26B
Avg. vol.
1.45M
Volume
4.33M
52-wk high
$27.64
52-wk low
$7.96
EPS
-$2.36
Beta
2.04
Shares outstanding
113.25M
No. of employees
206
Open
$19.45
High
$20.44
Low
$19.35
Mkt. cap
2.26B
Avg. vol.
1.45M
Volume
4.33M
52-wk high
$27.64
52-wk low
$7.96
EPS
-$2.36
Beta
2.04
Shares outstanding
113.25M
No. of employees
206
News stories
From sources across the web
About Immunome Inc
CEO-
Employees206
Founded2006
HeadquartersBothell, Washington, United States
SectorBiotechnology
Websiteimmunome.com
Analyst ratings
Based on 14 analysts giving stock ratings to IMNM in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for IMNM in the last 3 months.
Highest
Current $19.96
$40.00 (+100.40%)
Average
$35.77 (+79.21%)
Lowest
$30.00 (+50.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wedbush
Buy
Maintained
$31.00
+55.3%
06/12/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
$39.00
+95.4%
06/12/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
$36.00
+80.4%
06/11/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$40.00
+100.4%
06/11/2026
Chad Messer
Lake Street
Buy
Maintained
$30.00
+50.3%
06/01/2026
Biren Amin
Piper Sandler
Buy
Maintained
$33.00
+65.3%
06/01/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$40.00
+100.4%
06/01/2026
Lukas Shumway
Barclays
Buy
Maintained
$36.00
+80.4%
06/01/2026
Supawat Thongthip
Truist Financial
Buy
Initiated
$37.00
+85.4%
05/28/2026
Unknown Analyst
Barclays
Buy
Initiated
$36.00
+80.4%
05/28/2026
Andrew Berens
Leerink Partners
Buy
Maintained
$33.00
+65.3%
05/15/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$35.00
+75.4%
05/13/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$40.00
+100.4%
05/13/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$35.00
+75.4%
05/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/12/2026
Karina Rabayeva
Truist Financial
Buy
Maintained
-
-
03/05/2026
Sudan Loganathan
Stephens
Buy
Reiterated
$30.00
+50.3%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.02M
-
-
-
Cost of goods sold
40.45M
49.19M
50.77M
46.38M
Cost of revenue
40.45M
49.19M
50.77M
46.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.04M
10.94M
12.09M
12.95M
Operating expense
10.04M
10.94M
12.09M
12.95M
Total operating expenses
50.49M
60.14M
62.86M
59.33M
Operating income
-46.48M
-60.14M
-62.86M
-59.33M
Other non operating income
-
-
-
-
EBT including unusual items
-43.40M
-57.46M
-69.90M
-53.84M
EBT excluding unusual items
-43.40M
-57.46M
-59.90M
-53.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.40M
-57.46M
-69.90M
-53.84M
Net profit margin
-1,080.87%
-
-
-
Earnings per share
-0.50
-0.65
-0.76
-0.48
Interest and investment income
3.08M
2.68M
2.96M
5.49M
Interest expense
-
-
-
-
Net interest expenses
3.08M
2.68M
2.96M
5.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.84M
-59.55M
-62.23M
-58.73M
Gain or loss from assets sale
891.00K
-50.00K
55.00K
79.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of IMNM
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer